Publications by authors named "Mendel Jansen"

Claim this Profile
P
Population pharmacokinetics of ATR inhibitor berzosertib in phase I studies for different cancer types.
Nadia Terranova, Mendel Jansen, Martin Falk, Bart S Hendriks

Cancer Chemother Pharmacol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors.
Kathleen N Moore, Johanna C Bendell, Patricia M LoRusso, Anthony J Olszanski, Esther Zwick-Wallasch, Mendel Jansen

Invest New Drugs· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Repeated Doses of Mirogabalin in Healthy Asian Volunteers.
Mendel Jansen, Steven Warrington, Victor Dishy, Shoichi Ohwada, Lisa Johnson

Clin Pharmacol Drug Dev· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects.
Mendel Jansen, Jeanne Mendell, Alexander Currie, James Dow, Ling He

Clin Pharmacol Drug Dev· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis of patritumab, a HER3 inhibitor, in subjects with advanced non-small cell lung cancer (NSCLC) or solid tumors.
Satoshi Yoshiba, Mendel Jansen, Nobuko Matsushima, Shuquan Chen, Jeanne Mendell

Cancer Chemother Pharmacol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.
Marika Ciprotti, Niall C Tebbutt, Fook-Thean Lee, Sze-Ting Lee, Hui K Gan, Mendel Jansen

J Clin Oncol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080.
Ron J Keizer, Anubha Gupta, Melvin R Mac Gillavry, Mendel Jansen, Jantien Wanders

J Pharmacokinet Pharmacodyn· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies.
Sanjay Goel, Alain C Mita, Monica Mita, Eric K Rowinsky, Quincy S Chu, Mendel Jansen

Clin Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of population pharmacokinetic modeling in early clinical development of the anticancer agent E7820.
Ron J Keizer, Miren K Zamacona, Mendel Jansen, David Critchley, Jantien Wanders

Invest New Drugs· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog.
Mendel Jansen, Ian Darby, Thierry Abribat, Pascal Dubreuil, Eckhardt S Ferdinandi

Int J Pharm· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis